These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 395094

  • 1. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics.
    Kerner W, Beischer W, Maier V, Pfeiffer EF.
    Horm Metab Res Suppl; 1979; (8):71-80. PubMed ID: 395094
    [Abstract] [Full Text] [Related]

  • 2. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
    Christiansen JS, Svendsen PA, Deckert T.
    Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
    [Abstract] [Full Text] [Related]

  • 3. Control algorithms for artificial beta cell.
    Clemens AH.
    Horm Metab Res Suppl; 1979; (8):35-8. PubMed ID: 395086
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics.
    Schock A, Schultz M, Kerner W, Maier V, Pfeiffer EF.
    Horm Metab Res Suppl; 1979; (8):93-6. PubMed ID: 395097
    [Abstract] [Full Text] [Related]

  • 9. Continuous intravenous insulin therapy with a miniaturized open-loop system.
    Renner R, Hepp KD, Mehnert H, Franetzki M.
    Horm Metab Res Suppl; 1979; (8):186-90. PubMed ID: 395077
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus.
    Stavljenić A, Granić M, Topić B, Skrabalo Z.
    Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of an artificial beta cell in surgery.
    Horwitz DL, Schwartz SS.
    Horm Metab Res Suppl; 1979; (8):156-8. PubMed ID: 395072
    [Abstract] [Full Text] [Related]

  • 15. Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell.
    Altomare E, Moulin JP, Tavares S, Bourelly N, Lassmann V, Vague P.
    Horm Metab Res Suppl; 1979; (8):110-5. PubMed ID: 395065
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of 24-hour insulin requirements in IDDM patients during control by an artificial betacell and during conventional therapy.
    Christiansen JS, Svendsen PA, Mathiesen E, Rubin P, Deckert T.
    Horm Metab Res; 1981 Oct; 13(10):537-41. PubMed ID: 7028586
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.